Stay updated on Darolutamide in Addition to ADT Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.

Latest updates to the Darolutamide in Addition to ADT Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.3 was added to the page history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe history now shows a new version entry (58) on 2025-11-21 and an added Study Status section, reflecting an update to the trial's recruitment/status information.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page history shows the addition of 'Revision: v3.3.2' and the removal of 'Revision: v3.2.0', with no changes to study data, status, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedA general government funding/status notice was removed from the page, and the rest of the Version History and study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedNo substantive changes were detected in the record history; only minor UI formatting and the arrangement of version entries appear to be updated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedMajor change: the page now includes a government operating status notice and opens with a new version tag (v3.2.0); the previous version tag (v3.1.0) was removed.SummaryDifference9%

Stay in the know with updates to Darolutamide in Addition to ADT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.